Substance P and its metabolites in normal human tears.
暂无分享,去创建一个
T. Nishida | M. Yamada | M. Ogata | M. Kawai | Y. Mashima | M. Yamada
[1] M. Yamada,et al. Decreased substance P concentrations in tears from patients with corneal hypesthesia. , 2000, American journal of ophthalmology.
[2] T. Chikama,et al. Synergistic effect with Phe‐Gly‐Leu‐Met‐NH2 of the C‐terminal of substance P and insulin‐like growth factor‐1 on epithelial wound healing of rabbit cornea , 1999, British journal of pharmacology.
[3] K. Fukuda,et al. Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I , 1998, The Lancet.
[4] T. Chikama,et al. Up-regulation of integrin alpha 5 expression by combination of substance P and insulin-like growth factor-1 in rabbit corneal epithelial cells. , 1998, Biochemical and biophysical research communications.
[5] W. Tourtellotte,et al. Development and Evaluation of a Chromatographic Procedure for Partial Purification of Substance P with Quantitation by an Enzyme Immunoassay , 1998, Clinical Diagnostic Laboratory Immunology.
[6] C. Marfurt,et al. Peptidergic innervation of the rat cornea. , 1998, Experimental eye research.
[7] C. Murphy,et al. [Neurotrophic keratopathy--studies on substance P and the clinical significance of corneal sensation]. , 1997, Nippon Ganka Gakkai zasshi.
[8] R. Beuerman,et al. Detection of substance P in human tears by laser desorption mass spectrometry and immunoassay. , 1997, Current eye research.
[9] C. Murphy,et al. Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor 1. , 1997, Archives of ophthalmology.
[10] K. Tsubota,et al. Elevated levels of substance P in tears of patients with allergic conjunctivitis and vernal keratoconjunctivitis , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[11] T. Chikama,et al. Combined effects of substance P and insulin-like growth factor-1 on corneal epithelial wound closure of rabbit in vivo. , 1997, Current eye research.
[12] C. Murphy,et al. Synergistic effects of substance P with insulin‐like growth factor‐1 on epithelial migration of the cornea , 1996, Journal of cellular physiology.
[13] K. Rissler. Sample preparation, high-performance liquid chromatographic separation and determination of substance P-related peptides. , 1995, Journal of chromatography. B, Biomedical applications.
[14] C. Belmonte,et al. Neurotrophic influences on corneal epithelial cells. , 1994, Experimental eye research.
[15] C. Murphy,et al. Stimulation of epithelial cell growth by the neuropeptide substance P , 1993, Journal of cellular biochemistry.
[16] M. A. Pozo,et al. Effects of capsaicin on corneal wound healing. , 1990, Investigative ophthalmology & visual science.
[17] B. Malfroy,et al. Recombinant enkephalinase effectively inhibits substance P-induced miosis in the rabbit eye cup model. , 1990, Current eye research.
[18] J. Lehtosalo. Substance P-like immunoreactive trigeminal ganglion cells supplying the cornea , 2004, Histochemistry.
[19] F. Tsuji,et al. Tachykinins as enhancers of prostaglandin E2-induced intraocular inflammation. , 1998, Ocular immunology and inflammation.
[20] C. Maggi,et al. In vivo pupillary constrictor effects of substance P in man. , 1991, Life sciences.
[21] I. Iwamoto,et al. Inhibitory effect of tranilast on substance P-induced plasma extravasation in rat skin. , 1991, Immunopharmacology and immunotoxicology.
[22] H. Cramer,et al. High-performance liquid chromatographic separation of tachykinins using Tris-phosphate as the buffer component of the mobile phase. , 1990, Journal of chromatography.
[23] A. Cuello,et al. Substance P immunoreaction and acetylcholinesterase activity in the cornea and Gasserian ganglion. , 1983, Ophthalmic research.